Physician profile
Khaled Ajib
NPI 1265019368
$16,583.17
in general payments reported to CMS, 2019-2025
42 companies · $2,495 in 2025
The $2,495 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,432 · 2022: $2,796 · 2023: $2,686 · 2024: $5,173 · 2025: $2,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,450 · Travel and Lodging: $2,889 · Education: $16.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,449.65 |
| Travel and Lodging | $2,888.83 |
| Education | $16.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,354.92 | 2021-2025 | Interstim, Altaviva |
| Coloplast Corp | $1,919.81 | 2023-2024 | Titan |
| Intuitive Surgical, INC. | $1,701.34 | 2021 | |
| Procept Biorobotics Corporation | $1,644.13 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $943.73 | 2023-2025 | Orgovyx, Gemtesa |
| Axonics, INC. | $765.46 | 2021-2024 | Axonics |
| Pfizer INC. | $558.01 | 2021-2025 | |
| Teleflex LLC | $553.82 | 2021-2025 | Barrigel, Urolift |
| Janssen Biotech, INC. | $501.01 | 2021-2025 | Erleada, Akeega, Balversa |
| Myriad Genetic Laboratories, INC. | $433.68 | 2023-2025 | Prolaris |
| Accord Healthcare, INC. | $417.95 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $393.27 | 2022-2025 | |
| Myovant Sciences INC. | $371.93 | 2021-2022 | |
| Astellas Pharma US INC | $323.37 | 2021-2025 | Xtandi, Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $275.77 | 2022-2024 | Lynparza, Keytruda, Welireg |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $246.23 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $242.93 | 2021-2025 | Provenge |
| Abbvie INC. | $235.85 | 2021-2025 | Botox |
| Urovant Sciences INC | $209.02 | 2021-2022 | |
| Immunitybio, INC. | $207.16 | 2025 | |
| Ferring Pharmaceuticals INC. | $151.07 | 2025 | Adstiladrin |
| Antares Pharma, INC. | $150.50 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Tolmar Pharmaceuticals, INC. | $124.99 | 2021 | |
| Boston Scientific Corporation | $107.31 | 2021-2025 | Axonics, Ams 700, Ams 700 Cxr Rte Kit |
| Astrazeneca Pharmaceuticals LP | $92.18 | 2021-2023 | Lynparza |
| Endo USA, INC. | $89.07 | 2024-2025 | Xiaflex |
| Sun Pharmaceutical Industries INC. | $84.39 | 2022-2024 | Yonsa |
| Laborie Medical Technologies Corp. | $72.64 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| 180 Medical, INC. | $71.81 | 2021-2025 | Cure Catheter |
| Endo Pharmaceuticals INC. | $53.02 | 2021-2023 | Aveed, Xiaflex |
| Amgen INC. | $47.70 | 2021-2022 | |
| Halozyme INC | $45.60 | 2023 | |
| Janssen Pharmaceuticals, INC | $31.61 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.21 | 2025 | |
| Tempus Ai, INC | $20.66 | 2025 | Xt Cdx |
| Innovation Technologies INC | $19.94 | 2024 | Irrisept |
| Telix Pharmaceuticals | $18.90 | 2025 | Illuccix |
| Verity Pharmaceuticals INC. | $18.38 | 2025 | Tlando |
| Calyxo, INC. | $17.42 | 2025 | Cvac Aspiration System |
| Lilly USA, LLC | $15.80 | 2024 | Zepbound |
| Cook Medical LLC | $13.92 | 2023 | Fiber Dust |
| Acerus Pharmaceuticals Corporation | $13.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Ajib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.